Literature DB >> 348289

Essential hypertension and pregnancy.

R A Bear, N Erenrich.   

Abstract

Approximately 1% of pregnancies are complicated by essential hypertension. During pregnancy the blood pressure often stabilizes or improves. In patients with sustained hypertension, prospective controlled studies have demonstrated enhanced fetal survival when the blood pressure was controlled with antihypertensive medication. Such medication must be chosen carefully to avoid fetal and mateerial toxicity, and diuretics and salt restriction during pregnancy should be avoided. Among patients with essential hypertension the problem accelerates late in pregnancy in 2% to 11%; the acceleration may be predicted by determination of maternal mean arterial pressures and intravascular volumes early in pregnancy. The treatment of accelerated hypertension is identical to that of severe pre-eclampsia. Fetal loss is considerable but can be lessened by careful fetal and maternal monitoring and early controlled delivery. The risks of pregnancy in most patients with essential hypertension are small, and essential hypertension is not a uniform contraindication to pregnancy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 348289      PMCID: PMC1818219     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  34 in total

1.  An evaluation of human placental lactogen levels in hypertension of pregnancy.

Authors:  A M Kelly; P England; J D Lorimer; J C Ferguson; A D Govan
Journal:  Br J Obstet Gynaecol       Date:  1975-04

2.  The use of the oxytocin challenge test for antepartum clinical evaluation of uteroplacental respiratory function.

Authors:  R K Freeman
Journal:  Am J Obstet Gynecol       Date:  1975-02-15       Impact factor: 8.661

3.  Pregnancy and lupus nephritis. A detailed report of six cases with a review of the literature.

Authors:  R Bear
Journal:  Obstet Gynecol       Date:  1976-06       Impact factor: 7.661

4.  The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy.

Authors:  E W Page; R Christianson
Journal:  Am J Obstet Gynecol       Date:  1976-07-15       Impact factor: 8.661

5.  The placenta and newborn infant in hypertensive conditions.

Authors:  L A Cibils
Journal:  Am J Obstet Gynecol       Date:  1974-01-15       Impact factor: 8.661

6.  Fetal heart rate acceleration in relation to the oxytocin challenge test.

Authors:  G Farahani; A N Fenton
Journal:  Obstet Gynecol       Date:  1977-02       Impact factor: 7.661

7.  Hemodynamic and metabolic studies of a case of toxemia of pregnancy.

Authors:  U Freund; W French; R W Carlson; M H Weil; H Shubin
Journal:  Am J Obstet Gynecol       Date:  1977-01-15       Impact factor: 8.661

8.  Expansion of intravascular volume and fetal outcome in patients with chronic hypertension and pregnancy.

Authors:  F Arias
Journal:  Am J Obstet Gynecol       Date:  1975-11-15       Impact factor: 8.661

9.  Intravascular volume determinations and fetal outcome in hypertensive diseases of pregnancy.

Authors:  E C Soffronoff; B M Kaufmann; J F Connaughton
Journal:  Am J Obstet Gynecol       Date:  1977-01-01       Impact factor: 8.661

10.  Fetal outcome in trial of antihypertensive treatment in pregnancy.

Authors:  C W Redman
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.